LRP1 and glioblastoma: Angiopep-2 (TFFYGGSRGKRNNFKTEEY) is a peptide ligand of low-density lipoprotein receptor-related protein-1 (LRP1), which can cross the blood–brain barrier via receptor-mediated transcytosis and simultaneously target glioblastomas [76].